Icon times
Sun Pharmaceutical Industries Stock Fundamental Analysis - Financial Results & Equity Research | Invest Yadnya Stock-o-Meter

Sun Pharmaceutical Industries




Performing rate for the company



Price Chart (Only Standalone)

PE Price

Quarterly Results ( Figures in Rs. Crores.)

Profit & Loss ( Figures in Rs. Crores.)

Balance Sheet ( Figures in Rs. Crores.)

Cash Flows ( Figures in Rs. Crores.)

Historical Growths

Compounded Sales Growth
Compounded Profit Growth
Compounded Expense Growth
Stock Price CAGR

Ratios ()

Major Shareholders

Shareholders more than 1%

Corporate Action

No Data is available.
No Data is available.
No Data is available.
No Data is available.


Presentation & Earning Calls

Annual Reports

Credit Rating

No document is available
No document is available
No document is available
No document is available.




Sun Pharmaceutical Company Ltd is a Mumbai, India based Multi-national pharmaceutical company. Established by Mr Dilip Shanghvi in 1983, the company had its first base in Vapi, Gujarat. Initially, it started with a two-person marketing team and launched five products, but now they have emerged as one of the largest pharma companies standing at a net income of 530 million USD. 

The Indian pharmastry has become the third-largest producer globally in terms of volumes and develops into a business of $36.7 billion from $20 billion in 2015. Sun Pharma is the second biggest and the most profitable pharmaceutical company in India, as well as the largest pharmaceutical company by market capitalisation on the Indian exchanges. Breaking grounds with Its records Sun pharma is indeed one trusted INDIAN MNC known for its various quality pharma products and is listed in multiple stock exchanges worldwide.


Sun Pharma is into the research area, sells pharmaceutical formulations and active pharmaceutical ingredients (APIs). With its horizons and products as vast as space, some of the well-known ailments Sun Pharma provides products for are

  • cardiology 

  • psychiatry 

  • neurology 

  • gastroenterology  

  • diabetology

  •  It also provides APIs such as warfarin, carbamazepine, etodolac, clorazepate, anti-cancers, steroids, peptides, sex hormones, and controlled substances.


Sun Pharmaceuticals Ltd went through many mergers and acquisitions, but some of the game-changing were


  • In 1997, Sun took over Tamil Nadu's Dadha Pharmaceuticals Limited (TDPL), based in Chennai, nearly for their comprehensive gynaecology and oncology labels.

  • In 2008 Buys Chattem Chemicals, Inc., a manufacturer of controlled substances with an API facility.

  • On 6 April 2014, Sun Pharma declared that it would acquire 100% of Ranbaxy Laboratories Ltd., estimated at 4 billion USD. This turned tables for Sun, making them the largest pharmaceutical company in India, the largest Indian Pharma company in the US, and the 5th largest generic company globally.

  • In 2012 they acquired Dusa Pharmaceuticals, a dermatology based company.

  • Acquires majority stake in Taro Pharmaceutical Industries Limited, a multinational generic manufacturer with an established North American presence and a strong franchise in dermatology

  • In March 2015, Sun Pharma stated it had agreed to acquire GlaxoSmithKline's opiates company in Australia to grow its pain management collection.

  • In 2015 to strengthen its ophthalmic department, Sun Acquires InSite Vision Inc.'s portfolio in the USA.


  • In 1996 sun pharma expanded its network to 24 countries.

  • In 1998 Sun Pharma launched its first cardiology products that are sold to date.

  • In 2007 Sun Pharma demerged its research unit known as SPARC becoming the first pure research company to get listed in the Indian stock exchange.

  • In 2013 Acquiring Ranbaxy made Sun Pharma, the 5th largest generic company in the world.

  • In 2016 they launched their first ophthalmic product in the USA known as BromSite.

  • In 2018 Sun Pharma bagged the best CSR Practices from The Economic Times (ET).

  • In 2017 Mr Dilip Shanghvi got the Entrepreneur of the Year Award

             by All India Management Association (AIMA).

  • In 2016 Dilip Shanghvi was honoured with Padma Shri Award by the Government of India.

  • In 2015 Sun Pharma got India Pharma Research & Development Award by the Ministry of Chemicals & Fertilizers, Government of India.

  • Sun Pharma got listed among the world's 100 Most Innovative Companies IN 2014, 2013 Asia's 50 fab companies, and both in 2012, FORBES.


Invest Yadnya is an eLearning platform engaged in educating & simplifying the contents based on personal finance for all individuals. We have combined technology with financial planning expertise to assist an individual in meeting their financial objectives. We provide valuable time, money, as well as knowledge to create financial literacy in India.

We offer various products and services including, Personalized Financial Planning, Stock Market Analysis with eBook Subscriptions, Simplest Income Tax Information Bank, Comprehensive Mutual Fund Reviews, and Do-It-Yourself Financial Planning.

Invest Yadnya should be a choice because it offers unbiased and transparent stock analysis reports. Our work is knowledge-based and has specific proprietary methodologies and a stock research framework. We continuously keep updating our data and have the latest information available. 

We help our clients do extensive research on 950+ companies including, Sun Pharma stock fundamental analysis. You can find the latest Sun Pharma stock price on Invest Yadnya. We also provide our clients with the balance sheet of Sun Pharma. It helps the clients understand the financial position of the company before making any investment decisions. The Sun Pharma stock analysis helps the investors identify the intrinsic worth of the security. The Sun Pharma results provide a summary of how the business incurs revenues and expenses. We also offer our clients with the Sun pharma share price graph. 

A detailed stock article on Sun Pharma’s Performance Review is provided on our website, which offers an in-depth Sun pharma stock review. It gives an investor a sense of whether the company is growing, stable or deteriorating. This helps investors make a viable investment decision with a thorough discussion on Sun Pharma annual report & Sun Pharma research report.

Invest Yadnya offers numerous resources for Sun Pharma share analysis. With the available financials, price chart, ratios, etc., get a detailed Sun Pharma company analysis. With Invest Yadnya’s available resources, get an overview of the company, both from the qualitative and financial perspective. With this Sun Pharma fundamental analysis, the investors shall make a viable investment decision depending on your risk profile & other economic factors.

The Sun Pharma analysis gives the clients a better understanding of the company’s EPS, Debt-Equity Ratio etc. It helps clients take the first step in choosing which companies to invest in. 

The economic analysis of Sun Pharma overall helps allocate the equity in the Portfolio of an investor to add to its favourable returns.

To find the Sun Pharma ratio analysis & Sun Pharma stock chart, subscribe to our Equity Research and Stock Fundamental Analysis Tool, Stock-O-Meter.

Our website has information about 113 other Pharmaceuticals & Drugs companies that give insight into its financials. Companies include Divis Laboratories, Dr Reddys Laboratories, Cipla, Biocon, Aurobindo Pharma, Lupin, Torrent Pharmaceuticals, Cadila Healthcare, Abbott India, Glaxosmithkline Pharmaceuticals & many more.


premium Premium
free Free
Read More



Chat on WhatsApp
Caret UP Arrow
InvestYadnya Support
Typically replies in minutes
InvestYadnya Support
Hi there
Welcome to InvestYadnya.
We are available to assist you on WhatsApp.
Please click on the button below to chat with us.
(10 AM to 7 PM IST)
Chat with InvestYadnya